Last Updated: June 7, 2026

CLINICAL TRIALS PROFILE FOR CHIGLITAZAR

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Chiglitazar

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT02121717 ↗	Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients	Completed	Chipscreen Biosciences, Ltd.	Phase 3	The purpose of this study is to evaluate the efficacy and safety of Chiglitazar, compare with placebo.
NCT02173457 ↗	Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients	Completed	Chipscreen Biosciences, Ltd.	Phase 3	The purpose of this study is to evaluate the efficacy and safety of Chiglitazar, compare with Sitagliptin.
NCT04807348 ↗	Chiglitazar Added to Metformin for Type 2 Diabetes	Recruiting	Chipscreen Biosciences, Ltd.	Phase 3	The purpose of the trial is to evaluate the effect of Chiglitazar added to metformin to type 2 diabetes Inadequately controlled with metformin Monotherapy.
NCT05193916 ↗	Chiglitazar for NASH	Not yet recruiting	Chipscreen Biosciences, Ltd.	Phase 2	This study is a non-invasive exploratory phase II trial. Among patients who were clinically diagnosed as non-alcoholic steatohepatitis (NASH) with liver fibrosis accompanied by elevated triglycerides (TG) and insulin resistance, the efficacy and safety of chiglitazar sodium tablets 48mg , 64mg or placebo qd for 18 weeks were observed. The result will provide support for future clinical studies of Chiglitazar Sodium in the treatment of NASH.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Chiglitazar

Condition Name

Chart
Table

Condition Name
Intervention	Trials
Type 2 Diabetes	3
Chiglitazar	1
Relapse	1
Compensated Liver Cirrhosis	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH
Intervention	Trials
Diabetes Mellitus, Type 2	5
Diabetes Mellitus	4
Syndrome	2
Polycystic Ovary Syndrome	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Chiglitazar

Trials by Country

Map
Table

Trials by Country
Location	Trials
China	71
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Chiglitazar

Clinical Trial Phase

Chart
Table

Clinical Trial Phase
Clinical Trial Phase	Trials
PHASE2	1
PHASE1	1
Phase 3	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status
Clinical Trial Phase	Trials
Not yet recruiting	5
Enrolling by invitation	2
NOT_YET_RECRUITING	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Chiglitazar

Sponsor Name

Chart
Table

Sponsor Name
Sponsor	Trials
Chipscreen Biosciences, Ltd.	8
Affiliated Hospital of Nantong University	1
Shengjing Hospital	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type
Sponsor	Trials
Other	9
Industry	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.